CN1840036A - Chinese medicinal composite preparation capable of inhibiting growth of tumor cell - Google Patents
Chinese medicinal composite preparation capable of inhibiting growth of tumor cell Download PDFInfo
- Publication number
- CN1840036A CN1840036A CN 200510024738 CN200510024738A CN1840036A CN 1840036 A CN1840036 A CN 1840036A CN 200510024738 CN200510024738 CN 200510024738 CN 200510024738 A CN200510024738 A CN 200510024738A CN 1840036 A CN1840036 A CN 1840036A
- Authority
- CN
- China
- Prior art keywords
- radix
- fructus
- chinese medicinal
- poria
- kilograms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese compound preparation for inhibiting accretion of tumor cells, which is prepared from the following raw materials (by weight percent): root of pilose asiabell 3-50%, licorice root 3-50%, kudzuvine root 3-50%, rehamnnia root 3-50%, astragalus root 3-50%, poria cocos wolf 3-50%, radix salvia miltiorrhiza 3-50%, schisandra fruit 2-30%, Chinese angelica root 2-30%, ligustrum japonicum 2-30%, wolfberry fruit 2-30%, grape seed 3-50%, tea 1-20%, chrysanthemum flower 1-20%, and dried orange peel 1-20%. The medicament can be prepared into any dosage forms.
Description
Technical field
The present invention relates to a kind of compound Chinese medicinal preparation, particularly a kind of compound Chinese medicinal preparation with inhibition growth of tumour cell.
Background technology
Cancer is a big arch-criminal of harm people life and health at present, in order to save the life of suffering from cancer patient, need take operative treatment, but some patients are arranged because the reason of health can't undergo surgery, or behind operative treatment, need heavy dose of and secular Drug therapy, more existing anticancer Western medicine usually have more and suppress bone marrow, the serious digestive tract reaction of generation, and the liver of human body, kidney, the heart, nerve etc. are had toxicity, have reduced patient's immunity.There are some researches show that Chinese medicine contains very rich and varied active substance, as alkaloid, Polyphenols, flavonoid, Saponin class material or the like, reaction produces complexity and significant effects to interior free yl for they, can become the new medicine of treatment cancer.
Summary of the invention
The objective of the invention is to have Chinese medicine than strong anti-oxidation by screening, press the theory of Chinese medicine and pharmacy and free radical medical science, form a kind of new enhancing immunity that has, promote activities of antioxidant enzymes, suppress lipid peroxidation, the vigor of the setting upright compound Chinese medicinal preparation that suppresses growth of tumour cell, the present invention designs a kind of compound Chinese medicinal preparation that suppresses growth of tumour cell that has, and it is characterized in that the medicament of being made by following weight percentages: Radix Codonopsis 3-50%, Radix Glycyrrhizae 3-50%, Radix Puerariae 3-50%, Radix Rehmanniae 3-50%, Radix Astragali 3-50%, Poria 3-50%, Radix Salviae Miltiorrhizae 3-50%, Fructus Schisandrae Chinensis 2-30%, Radix Angelicae Sinensis 2-30%, Fructus Ligustri Lucidi 2-30%, Fructus Lycii 2-30%, Semen Vitis viniferae 3-50%, Folium Camelliae sinensis 1-20%, Flos Chrysanthemi 1-20%, Pericarpium Citri Reticulatae 1-20%.It is characterized in that the medicament made by following weight percentages: Radix Codonopsis 40%, Radix Rehmanniae 30%, Poria 4%, Radix Glycyrrhizae 3%, the Radix Astragali 3%, Radix Salviae Miltiorrhizae 3%, Radix Puerariae 3%, Radix Angelicae Sinensis 2%, Pericarpium Citri Reticulatae 1%, Fructus Schisandrae Chinensis 2%, Flos Chrysanthemi 1%, Fructus Lycii 2%, Folium Camelliae sinensis 1%, Fructus Ligustri Lucidi 2%, Semen Vitis viniferae 3%.It is characterized in that the medicament made by following weight percentages: Radix Codonopsis 3%, Radix Rehmanniae 3%, Poria 3%, Radix Glycyrrhizae 3%, the Radix Astragali 3%, Radix Salviae Miltiorrhizae 3%, Radix Puerariae 3%, Radix Angelicae Sinensis 4%, Pericarpium Citri Reticulatae 20%, Fructus Schisandrae Chinensis 4%, Flos Chrysanthemi 20%, Fructus Lycii 4%, Folium Camelliae sinensis 20%, Fructus Ligustri Lucidi 4%, Semen Vitis viniferae 3%.It is characterized in that the medicament made by following weight percentages: Radix Codonopsis 10%, Radix Rehmanniae 10%, Poria 10%, Radix Glycyrrhizae 10%, the Radix Astragali 10%, Radix Salviae Miltiorrhizae 10%, Radix Puerariae 10%, Radix Angelicae Sinensis 3%, Pericarpium Citri Reticulatae 3%, Fructus Schisandrae Chinensis 3%, Flos Chrysanthemi 2%, Fructus Lycii 2%, Folium Camelliae sinensis 3%, Fructus Ligustri Lucidi 3%, Semen Vitis viniferae 10%.It is characterized in that the medicament made by following weight percentages: Radix Codonopsis 4%, Radix Rehmanniae 4%, Poria 4%, Radix Glycyrrhizae 3%, the Radix Astragali 5%, Radix Salviae Miltiorrhizae 5%, Radix Puerariae 5%, Radix Angelicae Sinensis 15%, Pericarpium Citri Reticulatae 1%, Fructus Schisandrae Chinensis 15%, Flos Chrysanthemi 1%, Fructus Lycii 15%, Folium Camelliae sinensis 2%, Fructus Ligustri Lucidi 15%, Semen Vitis viniferae 5.Described medicament is a said dosage form on any pharmaceutics.A kind of preparation method with the compound Chinese medicinal preparation that suppresses growth of tumour cell, it is characterized in that: with Radix Codonopsis, Radix Rehmanniae, Poria, Radix Glycyrrhizae, the Radix Astragali, Radix Salviae Miltiorrhizae, Radix Puerariae, Radix Angelicae Sinensis, Pericarpium Citri Reticulatae, Fructus Schisandrae Chinensis, Flos Chrysanthemi, Fructus Lycii, Fructus Ligustri Lucidi, the selected roguing of Semen Vitis viniferae, clean and pulverize, adding an amount of water and ethanol fully soaks, be heated to the boiling back and extract, divide to slip and reclaim, low pressure concentrates, spray drying, Folium Camelliae sinensis are extracted separately to add behind the tea polyphenols and are added mixing tabletting or capsule or other preparation again.The present invention has nourishing blood and promoting blood circulation, promoting tissue regeneration by removing blood stasis, QI invigorating hepatoprotective, strengthening vital QI to eliminate pathogenic factors, enhancing immunity to human body, promotes activities of antioxidant enzymes, suppresses lipid peroxidation, suppresses functions such as growth of tumour cell.
Below in conjunction with example the present invention is elaborated:
The specific embodiment
Example 1: get 40 kilograms of Radix Codonopsis, 30 kilograms of Radix Rehmanniae, 4 kilograms in Poria, 3 kilograms in Radix Glycyrrhizae, 3 kilograms of the Radixs Astragali, 3 kilograms of Radix Salviae Miltiorrhizaes, 3 kilograms of Radix Puerariaes, 2 kilograms of Radix Angelicae Sinensis, 1 kilogram of Pericarpium Citri Reticulatae, 2 kilograms of Fructus Schisandrae Chinensis, 1 kilogram of Flos Chrysanthemi, 2 kilograms of Fructus Lycii, 1 kilogram of Folium Camelliae sinensis, 2 kilograms of Fructus Ligustri Lucidi, 3 kilograms of Semen Vitis viniferae.With the Radix Codonopsis in the foregoing description, Radix Rehmanniae, Poria, Radix Glycyrrhizae, the Radix Astragali, Radix Salviae Miltiorrhizae, Radix Puerariae, Radix Angelicae Sinensis, Pericarpium Citri Reticulatae, Fructus Schisandrae Chinensis, Flos Chrysanthemi, Fructus Lycii, Fructus Ligustri Lucidi, the selected roguing of Semen Vitis viniferae, clean and pulverize, adding an amount of water and ethanol fully soaks, being heated to the boiling back extracts, divide to slip and reclaim, low pressure concentrates, spray drying, and Folium Camelliae sinensis extracts separately to add behind the tea polyphenols and adds mixing tabletting or capsule or other preparation again.
Example 2: get 3 kilograms of Radix Codonopsis, 3 kilograms of Radix Rehmanniae, 3 kilograms in Poria, 3 kilograms in Radix Glycyrrhizae, 3 kilograms of the Radixs Astragali, 3 kilograms of Radix Salviae Miltiorrhizaes, 3 kilograms of Radix Puerariaes, 4 kilograms of Radix Angelicae Sinensis, 20 kilograms of Pericarpium Citri Reticulataes, 4 kilograms of Fructus Schisandrae Chinensis, 20 kilograms of Flos Chrysanthemis, 4 kilograms of Fructus Lycii, 20 kilograms of Folium Camelliae sinensis, 4 kilograms of Fructus Ligustri Lucidi, 3 kilograms of Semen Vitis viniferae.With the Radix Codonopsis in the foregoing description, Radix Rehmanniae, Poria, Radix Glycyrrhizae, the Radix Astragali, Radix Salviae Miltiorrhizae, Radix Puerariae, Radix Angelicae Sinensis, Pericarpium Citri Reticulatae, Fructus Schisandrae Chinensis, Flos Chrysanthemi, Fructus Lycii, Fructus Ligustri Lucidi, the selected roguing of Semen Vitis viniferae, clean and pulverize, adding an amount of water and ethanol fully soaks, being heated to the boiling back extracts, divide to slip and reclaim, low pressure concentrates, spray drying, and Folium Camelliae sinensis extracts separately to add behind the tea polyphenols and adds mixing tabletting or capsule or other preparation again.
Example 3: get 10 kilograms of Radix Codonopsis, 10 kilograms of Radix Rehmanniae, 10 kilograms in Poria, 10 kilograms in Radix Glycyrrhizae, 10 kilograms of the Radixs Astragali, 10 kilograms of Radix Salviae Miltiorrhizaes, 10 kilograms of Radix Puerariaes, 3 kilograms of Radix Angelicae Sinensis, 3 kilograms of Pericarpium Citri Reticulataes, 3 kilograms of Fructus Schisandrae Chinensis, 2 kilograms of Flos Chrysanthemis, 2 kilograms of Fructus Lycii, 3 kilograms of Folium Camelliae sinensis, 3 kilograms of Fructus Ligustri Lucidi, 10 kilograms of Semen Vitis viniferae.With the Radix Codonopsis in the foregoing description, Radix Rehmanniae, Poria, Radix Glycyrrhizae, the Radix Astragali, Radix Salviae Miltiorrhizae, Radix Puerariae, Radix Angelicae Sinensis, Pericarpium Citri Reticulatae, Fructus Schisandrae Chinensis, Flos Chrysanthemi, Fructus Lycii, Fructus Ligustri Lucidi, the selected roguing of Semen Vitis viniferae, clean and pulverize, adding an amount of water and ethanol fully soaks, being heated to the boiling back extracts, divide to slip and reclaim, low pressure concentrates, spray drying, and Folium Camelliae sinensis extracts separately to add behind the tea polyphenols and adds mixing tabletting or capsule or other preparation again.
Example 4: get 4 kilograms of Radix Codonopsis, 4 kilograms of Radix Rehmanniae, 4 kilograms in Poria, 3 kilograms in Radix Glycyrrhizae, 5 kilograms of the Radixs Astragali, 5 kilograms of Radix Salviae Miltiorrhizaes, 5 kilograms of Radix Puerariaes, 15 kilograms of Radix Angelicae Sinensis, 1 kilogram of Pericarpium Citri Reticulatae, 15 kilograms of Fructus Schisandrae Chinensis, 1 kilogram of Flos Chrysanthemi, 15 kilograms of Fructus Lycii, 2 kilograms of Folium Camelliae sinensis, 15 kilograms of Fructus Ligustri Lucidi, 5 kilograms of Semen Vitis viniferae.
With the Radix Codonopsis in the foregoing description, Radix Rehmanniae, Poria, Radix Glycyrrhizae, the Radix Astragali, Radix Salviae Miltiorrhizae, Radix Puerariae, Radix Angelicae Sinensis, Pericarpium Citri Reticulatae, Fructus Schisandrae Chinensis, Flos Chrysanthemi, Fructus Lycii, Fructus Ligustri Lucidi, the selected roguing of Semen Vitis viniferae, clean and pulverize, adding an amount of water and ethanol fully soaks, being heated to the boiling back extracts, divide to slip and reclaim, low pressure concentrates, spray drying, and Folium Camelliae sinensis extracts separately to add behind the tea polyphenols and adds mixing tabletting or capsule or other preparation again.
Claims (7)
1, a kind of compound Chinese medicinal preparation with inhibition growth of tumour cell is characterized in that the medicament of being made by following weight percentages: Radix Codonopsis 3-50%, Radix Glycyrrhizae 3-50%, Radix Puerariae 3-50%, Radix Rehmanniae 3-50%, Radix Astragali 3-50%, Poria 3-50%, Radix Salviae Miltiorrhizae 3-50%, Fructus Schisandrae Chinensis 2-30%, Radix Angelicae Sinensis 2-30%, Fructus Ligustri Lucidi 2-30%, Fructus Lycii 2-30%, Semen Vitis viniferae 3-50%, Folium Camelliae sinensis 1-20%, Flos Chrysanthemi 1-20%, Pericarpium Citri Reticulatae 1-20%
2, by the described a kind of compound Chinese medicinal preparation that suppresses growth of tumour cell that has of claim 1, it is characterized in that the medicament of making by following weight percentages: Radix Codonopsis 40%, Radix Rehmanniae 30%, Poria 4%, Radix Glycyrrhizae 3%, the Radix Astragali 3%, Radix Salviae Miltiorrhizae 3%, Radix Puerariae 3%, Radix Angelicae Sinensis 2%, Pericarpium Citri Reticulatae 1%, Fructus Schisandrae Chinensis 2%, Flos Chrysanthemi 1%, Fructus Lycii 2%, Folium Camelliae sinensis 1%, Fructus Ligustri Lucidi 2%, Semen Vitis viniferae 3%.
3, by the described a kind of compound Chinese medicinal preparation that suppresses growth of tumour cell that has of claim 1, it is characterized in that the medicament of making by following weight percentages: Radix Codonopsis 3%, Radix Rehmanniae 3%, Poria 3%, Radix Glycyrrhizae 3%, the Radix Astragali 3%, Radix Salviae Miltiorrhizae 3%, Radix Puerariae 3%, Radix Angelicae Sinensis 4%, Pericarpium Citri Reticulatae 20%, Fructus Schisandrae Chinensis 4%, Flos Chrysanthemi 20%, Fructus Lycii 4%, Folium Camelliae sinensis 20%, Fructus Ligustri Lucidi 4%, Semen Vitis viniferae 3%.
4, by the described a kind of compound Chinese medicinal preparation that suppresses growth of tumour cell that has of claim 1, it is characterized in that the medicament of making by following weight percentages: Radix Codonopsis 10%, Radix Rehmanniae 10%, Poria 10%, Radix Glycyrrhizae 10%, the Radix Astragali 10%, Radix Salviae Miltiorrhizae 10%, Radix Puerariae 10%, Radix Angelicae Sinensis 3%, Pericarpium Citri Reticulatae 3%, Fructus Schisandrae Chinensis 3%, Flos Chrysanthemi 2%, Fructus Lycii 2%, Folium Camelliae sinensis 3%, Fructus Ligustri Lucidi 3%, Semen Vitis viniferae 10%.
5, by the described a kind of compound Chinese medicinal preparation that suppresses growth of tumour cell that has of claim 1, it is characterized in that the medicament of making by following weight percentages: Radix Codonopsis 4%, Radix Rehmanniae 4%, Poria 4%, Radix Glycyrrhizae 3%, the Radix Astragali 5%, Radix Salviae Miltiorrhizae 5%, Radix Puerariae 5%, Radix Angelicae Sinensis 15%, Pericarpium Citri Reticulatae 1%, Fructus Schisandrae Chinensis 15%, Flos Chrysanthemi 1%, Fructus Lycii 15%, Folium Camelliae sinensis 2%, Fructus Ligustri Lucidi 15%, Semen Vitis viniferae 5.
6, by the described a kind of compound Chinese medicinal preparation that suppresses growth of tumour cell that has of claim 1, it is characterized in that: described medicament is a said dosage form on any pharmaceutics.
7, the described a kind of preparation method of claim 1 with the compound Chinese medicinal preparation that suppresses growth of tumour cell, it is characterized in that: with Radix Codonopsis, Radix Rehmanniae, Poria, Radix Glycyrrhizae, the Radix Astragali, Radix Salviae Miltiorrhizae, Radix Puerariae, Radix Angelicae Sinensis, Pericarpium Citri Reticulatae, Fructus Schisandrae Chinensis, Flos Chrysanthemi, Fructus Lycii, Fructus Ligustri Lucidi, the selected roguing of Semen Vitis viniferae, clean and pulverize, adding an amount of water and ethanol fully soaks, being heated to the boiling back extracts, divide to slip and reclaim, low pressure concentrates, spray drying, Folium Camelliae sinensis are extracted separately to add behind the tea polyphenols and are added mixing tabletting or capsule or preparation again.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510024738 CN1840036A (en) | 2005-03-29 | 2005-03-29 | Chinese medicinal composite preparation capable of inhibiting growth of tumor cell |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510024738 CN1840036A (en) | 2005-03-29 | 2005-03-29 | Chinese medicinal composite preparation capable of inhibiting growth of tumor cell |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1840036A true CN1840036A (en) | 2006-10-04 |
Family
ID=37029339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510024738 Pending CN1840036A (en) | 2005-03-29 | 2005-03-29 | Chinese medicinal composite preparation capable of inhibiting growth of tumor cell |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1840036A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102178791A (en) * | 2011-04-27 | 2011-09-14 | 宁夏大学 | Toxin expelling and acne removing agent and preparation method and use method thereof |
| CN103908495A (en) * | 2014-04-12 | 2014-07-09 | 陈欣 | Traditional Chinese medicine composition for improving postoperative immunity of cancer patient and preparation method of traditional Chinese medicine composition |
| CN104740541A (en) * | 2015-04-21 | 2015-07-01 | 杨波 | Health-care traditional Chinese medicine powder for protecting liver, detoxifying and recovering liver functions |
| CN105878743A (en) * | 2016-07-07 | 2016-08-24 | 王瑜琳 | Traditional Chinese medicine composition for inhibiting tumors |
| CN108785520A (en) * | 2017-04-30 | 2018-11-13 | 沈阳馨家懿商贸有限公司 | Inhibit tumour, anti-hunger, removing toxic substances, the drug of strengthen immunity and preparation method |
| CN109512857A (en) * | 2018-11-29 | 2019-03-26 | 山东汉泰生物科技有限公司 | A kind of mannose-Chinese herbal compounds inhibiting tumour growth |
| CN114848770A (en) * | 2022-06-28 | 2022-08-05 | 上海饮立生物科技有限公司 | Traditional Chinese medicine composition for treating rehabilitation of tumor patients after radiotherapy and chemotherapy as well as preparation method and application thereof |
-
2005
- 2005-03-29 CN CN 200510024738 patent/CN1840036A/en active Pending
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102178791A (en) * | 2011-04-27 | 2011-09-14 | 宁夏大学 | Toxin expelling and acne removing agent and preparation method and use method thereof |
| CN103908495A (en) * | 2014-04-12 | 2014-07-09 | 陈欣 | Traditional Chinese medicine composition for improving postoperative immunity of cancer patient and preparation method of traditional Chinese medicine composition |
| CN104740541A (en) * | 2015-04-21 | 2015-07-01 | 杨波 | Health-care traditional Chinese medicine powder for protecting liver, detoxifying and recovering liver functions |
| CN104740541B (en) * | 2015-04-21 | 2019-05-14 | 杨波 | A kind of protecting liver and detoxication restores the Chinese medicine powder for health care of liver function |
| CN105878743A (en) * | 2016-07-07 | 2016-08-24 | 王瑜琳 | Traditional Chinese medicine composition for inhibiting tumors |
| CN108785520A (en) * | 2017-04-30 | 2018-11-13 | 沈阳馨家懿商贸有限公司 | Inhibit tumour, anti-hunger, removing toxic substances, the drug of strengthen immunity and preparation method |
| CN109512857A (en) * | 2018-11-29 | 2019-03-26 | 山东汉泰生物科技有限公司 | A kind of mannose-Chinese herbal compounds inhibiting tumour growth |
| CN114848770A (en) * | 2022-06-28 | 2022-08-05 | 上海饮立生物科技有限公司 | Traditional Chinese medicine composition for treating rehabilitation of tumor patients after radiotherapy and chemotherapy as well as preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102266445B (en) | Eye protection Chinese medicinal composition with health care and treatment effects | |
| US7569234B2 (en) | Herb composition for treating lung cancer and preparation method thereof | |
| CN101773636A (en) | Antitumor nanometer Chinese medicine and production method thereof | |
| CN1840036A (en) | Chinese medicinal composite preparation capable of inhibiting growth of tumor cell | |
| CN105250675A (en) | Traditional Chinese medicine combination for preparing medicine for treating tumour and leukemia | |
| CN102512615B (en) | Traditional Chinese medicinal composition used for cancer recovery stage | |
| CN102727779B (en) | Pharmaceutical composition for treating ovarian cysts and preparation method thereof | |
| CN101361866A (en) | Use of morinda traditional Chinese medicine combination in preparing medicine for treating osteoporosis | |
| CN101611865A (en) | Health-care tea for activating yang and tonifying qi | |
| CN101406594B (en) | Chinese medicine for treating tumor of lung | |
| CN101530490B (en) | Traditional Chinese medicine for treating bladder cancer | |
| CN102861236A (en) | Anti-tumor preparation made of pure traditional Chinese medicines | |
| CN101953986A (en) | Method for preparing Chinese medicinal preparation for treating Qi deficiency and blood deficiency | |
| CN105535855A (en) | Traditional Chinese medicinal composition for treating hepatitis B and preparation method thereof | |
| CN101843778B (en) | Chinese medicament for treating ichthyosis | |
| CN101406566A (en) | Chinese medicine for treating gastric cancer | |
| CN1839929A (en) | Chinese traditional compound formulation for protecting liver | |
| CN116270830B (en) | Anti-radiation traditional Chinese medicine composition and application thereof | |
| CN1742866A (en) | Anti-cancer Chinese medicine capsule preparation | |
| CN103736051A (en) | Hemangioma nursing medicament and preparation method thereof | |
| CN1175875C (en) | Medicine made of lysimachia for treating hepatobiliary calculus and its prescription | |
| CN101884762B (en) | Traditional Chinese medicine for treating emphysema | |
| CN101843740A (en) | Chinese medicament for treating climacteric syndromes | |
| CN101850055B (en) | Chinese medicament for treating coronary heart diseases | |
| CN100571739C (en) | Herbal mixture of treatment cardiovascular disease and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Open date: 20061004 |